Back to Authors

Sellier-Leclerc, Anne-Laure A.

Mayo Clinic

Hôpital Femme Mère Enfant

Citations 5

Lumasiran for Primary Hyperoxaluria Type 1 and Impaired Kidney Function: 24-Month Analysis of the Phase 3 ILLUMINATE-C Trial
Magen, Daniella , Sellier-Leclerc, Anne-Laure A., Shasha‐Lavsky, Hadas , Šimková, Eva, Devresse, Arnaud , Michael, Mini , Frishberg, Yaacov, Mourani, Chebl, Saqan, Rola , Guzzo, Isabella, Makarova, Nune , Willey, Richard G., Kaspar, Cristin , Gansner, John M. , Groothoff, Jaap W. , Lieske, John C. , Sellier‐Leclerc, Anne‐Laure , Bakkaloglu, Sevcan Azime , Singer, Richard , Guzzo, Isabella

Journal of the American Society of Nephrology | May 18, 2024 | Volume: 34 | Issue: 11S | Pages: 566-566

10.1681/asn.20233411s1566b Get It

Lumasiran for Patients With Primary Hyperoxaluria Type 1 and Impaired Kidney Function: 12-Month Analysis of the Phase 3 ILLUMINATE-C Trial
Frishberg, Yaacov, Michael, Mini , Groothoff, Jaap W. , Shasha‐Lavsky, Hadas , Šimková, Eva, Sellier-Leclerc, Anne-Laure A., Devresse, Arnaud , Egziabher, Fitsum Guebre, Mourani, Chebl, Saqan, Rola , Willey, Richard G., Gansner, John M. , Magen, Daniella , Lieske, John C. , Sellier‐Leclerc, Anne‐Laure , Bakkaloglu, Sevcan Azime , Singer, Richard

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 416-416

10.1681/asn.20223311s1416a Get It

ILLUMINATE-C, a Single-Arm, Phase 3 Study of Lumasiran in Patients with Primary Hyperoxaluria Type 1 and CKD Stages 3b-5, Including Those on Hemodialysis
Michael, Mini , Groothoff, Jaap W. , Shasha‐Lavsky, Hadas , Frishberg, Yaacov, Šimková, Eva, Sellier-Leclerc, Anne-Laure A., Devresse, Arnaud , Egziabher, Fitsum Guebre, Mourani, Chebl, Saqan, Rola , Willey, Richard G., Habtemarian, Bahru A., Bhan, Ishir , McGregor, Tracy L., Magen, Daniella , Lieske, John C. , Sellier‐Leclerc, Anne‐Laure , Bakkaloglu, Sevcan Azime , Singer, Richard

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 32 | Issue: 10S | Pages: B2-B2

10.1681/asn.20213210s1b2a Get It

12-Month Analysis of ILLUMINATE-A, a Phase 3 Study of Lumasiran: Sustained Oxalate Lowering and Kidney Stone Event Rates in Primary Hyperoxaluria Type 1
Saland, Jeffrey M. , Groothoff, Jaap W. , Frishberg, Yaacov, Hulton, Sally A., Koren, Michael J. , Overcash, Jeffrey S., Sellier-Leclerc, Anne-Laure A., Shasha‐Lavsky, Hadas , Magen, Daniella , Moochhala, Shabbir H. , Šimková, Eva, Sas, David J. , Meliambro, Kristin, Ngo, Taylor , Fujita, Kenji P. , Gansner, John M. , McGregor, Tracy L., Sellier‐Leclerc, Anne‐Laure , Deschênes, Georges , Hayes, Wesley Nathan , Fuster, Daniel Guido , Coenen, Martin , Garrelfs, Sander F. , Lieske, John C.

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: B8-B8

10.1681/asn.20203110s1b8c Get It